Search

Your search keyword '"Sahin Coban"' showing total 4 results
Start Over Author "Sahin Coban" Journal alimentary pharmacologytherapeutics
4 results on '"Sahin Coban"'

1. Letter: a hidden cause of anaemia in inflammatory bowel disease patients - coeliac disease

Author

Y. Ustun, F. Karaahmet, Sahin Coban, İlhami Yüksel, and S. Kılıncalp

Subjects
Male, medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, MEDLINE, Anemia, medicine.disease, Inflammatory bowel disease, Coeliac disease, Crohn Disease, Internal medicine, Medicine, Humans, Pharmacology (medical), Colitis, Ulcerative, Female, Colitis, business
Published
2013

2. Letter: vitamin D supplementation and the irritable bowel syndrome

Author

F. Karaahmet, O. Başar, Osman Yüksel, Sahin Coban, and I. Yksel

Subjects
medicine.medical_specialty, Hepatology, Vitamin d supplementation, business.industry, Gastroenterology, medicine.disease, Vitamin D Deficiency, Irritable Bowel Syndrome, Internal medicine, medicine, Humans, Pharmacology (medical), Vitamin D, business, Irritable bowel syndrome
Published
2012

3. Letter: Clostridium difficile colitis in patients with ulcerative colitis

Author

F. Karaahmet, O. Başar, Sahin Coban, İlhami Yüksel, and Osman Yüksel

Subjects
Enterocolitis, Male, medicine.medical_specialty, Hepatology, business.industry, Clostridioides difficile, Gastroenterology, medicine.disease, Ulcerative colitis, Clostridium Difficile Colitis, Internal medicine, Medicine, Humans, Pharmacology (medical), In patient, Colitis, Ulcerative, Female, medicine.symptom, Colitis, business, Enterocolitis, Pseudomembranous
Published
2012

4. Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis

Author

Ramazan Idilman, Sahin Coban, D. Mizrak, R. Emral, D. Corapcioglu, Ali Özden, Ali Riza Uysal, Esra Erden, Mehmet Bektas, Irfan Soykan, M. Sayki, and Beyza Doganay

Subjects
Adult, Male, medicine.medical_specialty, Diet therapy, medicine.medical_treatment, Rosiglitazone, Insulin resistance, Internal medicine, medicine, Humans, Hypoglycemic Agents, Pharmacology (medical), Aspartate Aminotransferases, Adverse effect, Pancreatic hormone, Hepatology, business.industry, Insulin, Fatty liver, Gastroenterology, Alanine Transaminase, Middle Aged, medicine.disease, Metformin, Exercise Therapy, Fatty Liver, Endocrinology, Treatment Outcome, Female, Thiazolidinediones, Steatohepatitis, Insulin Resistance, business, medicine.drug, Diet Therapy, Follow-Up Studies
Abstract

Summary Background Currently, although only a few therapies normalize the liver test abnormalities with/without improving the liver histology, no pharmacologic therapy has proved to be effective for the treatment of non-alcoholic steatohepatitis. Aim To investigate the role of insulin sensitizers in the treatment of individuals with non-alcoholic steatohepatitis (NASH). Methods A total of 74 individuals with NASH (male/female, 44/30; mean age, 47.2 ± 9.0 years) were enrolled. Participants were divided into two distinct groups: group 1 (n = 25) participants were administered a conventional diet and exercise programme while those in group 2 (n = 49) were administered the diet and exercise programme plus insulin sensitizers. Results With respect to baseline metabolic, biochemical and histological parameters, no significant differences were observed between the two groups (P > 0.05). Insulin sensitizers significantly improved metabolic parameters (homeostasis model assessment-insulin resistance score, P

Published
2008

Catalog

Books, media, physical & digital resources
See catalog results